Skip to main content
Top
Published in:

Open Access 26-07-2023 | Polycystic Ovary Syndrome

Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review

Authors: Mafalda V. Moreira, Emídio Vale-Fernandes, Inês C. Albergaria, Marco G. Alves, Mariana P. Monteiro

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 6/2023

Login to get access

Abstract

Polycystic ovary syndrome (PCOS) is recognized as one of the most prevalent endocrinopathy in women at reproductive age. As affected women tend to have poorer assisted reproductive technology (ART) outcomes, PCOS has been suggested to endanger oocyte quality and competence development. The aim of this systematic review was to summarize the available evidence on how the follicular fluid (FF) profile of women with PCOS undergoing in vitro fertilization (IVF) treatment differs from the FF of normo-ovulatory women. For that, an electronic search in PubMed and Web of Science databases was conducted (up to December 2021). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses - PRISMA guidelines were followed, and the Newcastle-Ottawa Scale was used to assess the risk of bias in the included studies. Data retrieved from papers included (n=42), revealed that the FF composition of women with PCOS compared to those without PCOS predominantly diverged at the following molecular classes: oxidative stress, inflammatory biomarkers, growth factors and hormones. Among those biomarkers, some were proposed as being closely related to pathophysiological processes, strengthening the hypothesis that low-grade inflammation and oxidative stress play a critical role in the pathogenesis of PCOS. Notwithstanding, it should be noticed that the available data on PCOS FF fingerprints derives from a limited number of studies conducted in a relatively small number of subjects. Furthermore, phenotypic heterogeneity of PCOS hampers wider comparisons and weakens putative conclusions. Therefore, future studies should be focused at comparing well characterized patient subgroups according to phenotypes.
Literature
1.
go back to reference Yildiz BO, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067–73.PubMedCrossRef Yildiz BO, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067–73.PubMedCrossRef
2.
go back to reference Balen AH, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.PubMedCrossRef Balen AH, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.PubMedCrossRef
3.
go back to reference Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.PubMedCrossRef Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.PubMedCrossRef
4.
go back to reference Franks S. Polycystic Ovary Syndrome. 1995;333(13):853–61. Franks S. Polycystic Ovary Syndrome. 1995;333(13):853–61.
5.
go back to reference Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility. 2018;110(3):364–79.PubMedPubMedCentralCrossRef Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility. 2018;110(3):364–79.PubMedPubMedCentralCrossRef
6.
go back to reference Artimani T, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecological Endocrinology. 2018;34(2):148–52.PubMedCrossRef Artimani T, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecological Endocrinology. 2018;34(2):148–52.PubMedCrossRef
7.
go back to reference Piomboni P, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31(10):1269–76.PubMedPubMedCentralCrossRef Piomboni P, et al. Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31(10):1269–76.PubMedPubMedCentralCrossRef
8.
go back to reference Rajani S, et al. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J Hum Reprod Sci. 2012;5(2):187–93.PubMedPubMedCentralCrossRef Rajani S, et al. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J Hum Reprod Sci. 2012;5(2):187–93.PubMedPubMedCentralCrossRef
9.
go back to reference Yilmaz N, et al. Follicular fluid total antioxidant capacity levels in PCOS. J Obstet Gynaecol. 2016;36(5):654–7.PubMedCrossRef Yilmaz N, et al. Follicular fluid total antioxidant capacity levels in PCOS. J Obstet Gynaecol. 2016;36(5):654–7.PubMedCrossRef
10.
go back to reference Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17–33.PubMedCrossRef Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17(1):17–33.PubMedCrossRef
11.
go back to reference Piltonen TT. Polycystic ovary syndrome: Endometrial markers. Best Pract Res Clin Obstet Gynaecol. 2016;37:66–79.PubMedCrossRef Piltonen TT. Polycystic ovary syndrome: Endometrial markers. Best Pract Res Clin Obstet Gynaecol. 2016;37:66–79.PubMedCrossRef
12.
go back to reference Da Broi MG, et al. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. Journal of Assisted Reproduction and Genetics. 2018;35(5):735–51.PubMedPubMedCentralCrossRef Da Broi MG, et al. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. Journal of Assisted Reproduction and Genetics. 2018;35(5):735–51.PubMedPubMedCentralCrossRef
13.
go back to reference Palomba S, Daolio J, La Sala GB. Oocyte Competence in Women with Polycystic Ovary Syndrome. Trends in Endocrinology and Metabolism. 2017;28(3):186–98.PubMedCrossRef Palomba S, Daolio J, La Sala GB. Oocyte Competence in Women with Polycystic Ovary Syndrome. Trends in Endocrinology and Metabolism. 2017;28(3):186–98.PubMedCrossRef
15.
go back to reference Jančar N, et al. Effect of apoptosis and reactive oxygen species productionin human granulosa cells on oocyte fertilizationand blastocyst development. Journal of Assisted Reproduction and Genetics. 2007;24(2):91–7.PubMedPubMedCentralCrossRef Jančar N, et al. Effect of apoptosis and reactive oxygen species productionin human granulosa cells on oocyte fertilizationand blastocyst development. Journal of Assisted Reproduction and Genetics. 2007;24(2):91–7.PubMedPubMedCentralCrossRef
16.
go back to reference Zhao Y, et al. Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome. Scientific reports. 2022;12(1):4359–4359.PubMedPubMedCentralCrossRef Zhao Y, et al. Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome. Scientific reports. 2022;12(1):4359–4359.PubMedPubMedCentralCrossRef
17.
go back to reference Ambekar AS, et al. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744–53.PubMedCrossRef Ambekar AS, et al. Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development. J Clin Endocrinol Metab. 2015;100(2):744–53.PubMedCrossRef
18.
go back to reference Sun Z, et al. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reproductive Biology and Endocrinology. 2019;17(1):45.PubMedPubMedCentralCrossRef Sun Z, et al. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reproductive Biology and Endocrinology. 2019;17(1):45.PubMedPubMedCentralCrossRef
20.
go back to reference Shamseer L, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ : British Medical Journal. 2015;349: g7647.CrossRef Shamseer L, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ : British Medical Journal. 2015;349: g7647.CrossRef
21.
go back to reference Artimani T, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2018;34(2):148–52.PubMedCrossRef Artimani T, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2018;34(2):148–52.PubMedCrossRef
22.
go back to reference Chattopadhayay R, et al. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest. 2010;69(3):197–202.PubMedCrossRef Chattopadhayay R, et al. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest. 2010;69(3):197–202.PubMedCrossRef
23.
go back to reference Naigaonkar A, et al. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome. J Assist Reprod Genet. 2021;38(10):2609–23.PubMedPubMedCentralCrossRef Naigaonkar A, et al. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome. J Assist Reprod Genet. 2021;38(10):2609–23.PubMedPubMedCentralCrossRef
24.
go back to reference Gongadashetti K, et al. Follicular fluid oxidative stress biomarkers and ART outcomes in PCOS women undergoing in vitro fertilization: A cross-sectional study. Int J Reprod Biomed. 2021;19(5):449–56.PubMedPubMedCentral Gongadashetti K, et al. Follicular fluid oxidative stress biomarkers and ART outcomes in PCOS women undergoing in vitro fertilization: A cross-sectional study. Int J Reprod Biomed. 2021;19(5):449–56.PubMedPubMedCentral
25.
go back to reference Seleem AK, et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet. 2014;31(4):499–504.PubMedPubMedCentralCrossRef Seleem AK, et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet. 2014;31(4):499–504.PubMedPubMedCentralCrossRef
27.
go back to reference Wang B, et al. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. J Assist Reprod Genet. 2016;33(7):959–65.PubMedPubMedCentralCrossRef Wang B, et al. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome. J Assist Reprod Genet. 2016;33(7):959–65.PubMedPubMedCentralCrossRef
28.
go back to reference Wang Y, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecol Endocrinol. 2019;35(12):1072–7.PubMedCrossRef Wang Y, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecol Endocrinol. 2019;35(12):1072–7.PubMedCrossRef
29.
go back to reference Zhang H, et al. IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization. J Reprod Immunol. 2020;138: 103083.PubMedCrossRef Zhang H, et al. IL-18 and IL-18 binding protein concentration in ovarian follicular fluid of women with unexplained infertility to PCOS during in vitro fertilization. J Reprod Immunol. 2020;138: 103083.PubMedCrossRef
30.
go back to reference Niu Z, et al. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. Cytokine. 2017;91:180–6.PubMedCrossRef Niu Z, et al. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. Cytokine. 2017;91:180–6.PubMedCrossRef
31.
go back to reference Zhou D, et al. Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2017;218:106–12.PubMedCrossRef Zhou D, et al. Increased expression of PGRN protein in follicular fluid and mRNA in granulosa cells in overweight patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2017;218:106–12.PubMedCrossRef
32.
go back to reference Ozörnek MH, et al. Epidermal growth factor and leukemia inhibitory factor levels in follicular fluid. Association with in vitro fertilization outcome. J Reprod Med. 1999;44(4):367-369. Ozörnek MH, et al. Epidermal growth factor and leukemia inhibitory factor levels in follicular fluid. Association with in vitro fertilization outcome. J Reprod Med. 1999;44(4):367-369.
33.
go back to reference Li Z, et al. Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome. Reprod Biomed Online. 2018;36(4):483–9.PubMedCrossRef Li Z, et al. Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome. Reprod Biomed Online. 2018;36(4):483–9.PubMedCrossRef
34.
go back to reference Maillard-Lefebvre H, et al. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology. 2009;48(10):1190–6.PubMedCrossRef Maillard-Lefebvre H, et al. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology. 2009;48(10):1190–6.PubMedCrossRef
35.
36.
go back to reference Wang B, et al. Decreased levels of sRAGE in follicular fluid from patients with PCOS. Reproduction. 2017;153(3):285–92.PubMedCrossRef Wang B, et al. Decreased levels of sRAGE in follicular fluid from patients with PCOS. Reproduction. 2017;153(3):285–92.PubMedCrossRef
37.
go back to reference Kahyaoglu I, et al. Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome. Cytokine. 2015;74(1):113–6.PubMedCrossRef Kahyaoglu I, et al. Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome. Cytokine. 2015;74(1):113–6.PubMedCrossRef
38.
go back to reference Kudsy M, Alhalabi M, Al-Quobaili F. Follicular fluid Vascular Endothelial Growth Factor (VEGF) could be a predictor for pregnancy outcome in normo-responders and polycystic ovary syndrome women undergoing IVF/ICSI treatment cycles. Middle East Fertility Society Journal. 2016;21(1):52–6.CrossRef Kudsy M, Alhalabi M, Al-Quobaili F. Follicular fluid Vascular Endothelial Growth Factor (VEGF) could be a predictor for pregnancy outcome in normo-responders and polycystic ovary syndrome women undergoing IVF/ICSI treatment cycles. Middle East Fertility Society Journal. 2016;21(1):52–6.CrossRef
39.
go back to reference Savchev SI, et al. Follicular fluid-specific distribution of vascular endothelial growth factor isoforms and sFlt-1 in patients undergoing IVF and their correlation with treatment outcomes. Reprod Sci. 2010;17(11):1036–42.PubMedCrossRef Savchev SI, et al. Follicular fluid-specific distribution of vascular endothelial growth factor isoforms and sFlt-1 in patients undergoing IVF and their correlation with treatment outcomes. Reprod Sci. 2010;17(11):1036–42.PubMedCrossRef
40.
go back to reference Tal R, et al. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation. Reprod Biol Endocrinol. 2014;12:82.PubMedPubMedCentralCrossRef Tal R, et al. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation. Reprod Biol Endocrinol. 2014;12:82.PubMedPubMedCentralCrossRef
41.
go back to reference Fang L, et al. High GDF-8 in follicular fluid is associated with a low pregnancy rate in IVF patients with PCOS. Reproduction. 2020;160(1):11–9.PubMedCrossRef Fang L, et al. High GDF-8 in follicular fluid is associated with a low pregnancy rate in IVF patients with PCOS. Reproduction. 2020;160(1):11–9.PubMedCrossRef
42.
go back to reference Uzumcu M, et al. Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro. Reproduction. 2006;132(2):291–9.PubMedCrossRef Uzumcu M, et al. Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro. Reproduction. 2006;132(2):291–9.PubMedCrossRef
43.
go back to reference Guglielmo MC, et al. The effect of hepatocyte growth factor on the initial stages of mouse follicle development. Journal of Cellular Physiology. 2011;226(2):520–9.PubMedCrossRef Guglielmo MC, et al. The effect of hepatocyte growth factor on the initial stages of mouse follicle development. Journal of Cellular Physiology. 2011;226(2):520–9.PubMedCrossRef
44.
go back to reference Şahin N, et al. The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome. Fertility and Sterility. 2013;99(1):264-269.e3.PubMedCrossRef Şahin N, et al. The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome. Fertility and Sterility. 2013;99(1):264-269.e3.PubMedCrossRef
45.
go back to reference Buratini J Jr, et al. Expression and Function of Fibroblast Growth Factor 10 and Its Receptor, Fibroblast Growth Factor Receptor 2B, in Bovine Follicles1. Biology of Reproduction. 2007;77(4):743–50.PubMedCrossRef Buratini J Jr, et al. Expression and Function of Fibroblast Growth Factor 10 and Its Receptor, Fibroblast Growth Factor Receptor 2B, in Bovine Follicles1. Biology of Reproduction. 2007;77(4):743–50.PubMedCrossRef
46.
go back to reference Liu Y, et al. Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence. Journal of Ovarian Research. 2018;11(1):87.PubMedPubMedCentralCrossRef Liu Y, et al. Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence. Journal of Ovarian Research. 2018;11(1):87.PubMedPubMedCentralCrossRef
47.
go back to reference Şahin N, et al. The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome. Fertil Steril. 2013;99(1):264-269.e3.PubMedCrossRef Şahin N, et al. The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome. Fertil Steril. 2013;99(1):264-269.e3.PubMedCrossRef
48.
go back to reference Liu Y, et al. Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence. J Ovarian Res. 2018;11(1):87.PubMedPubMedCentralCrossRef Liu Y, et al. Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competence. J Ovarian Res. 2018;11(1):87.PubMedPubMedCentralCrossRef
49.
go back to reference Garruti G, et al. Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. Biomed Res Int. 2014;2014: 980429.PubMedPubMedCentralCrossRef Garruti G, et al. Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. Biomed Res Int. 2014;2014: 980429.PubMedPubMedCentralCrossRef
50.
go back to reference Hu KL, et al. Increased Expression of KISS1 and KISS1 Receptor in Human Granulosa Lutein Cells-Potential Pathogenesis of Polycystic Ovary Syndrome. Reprod Sci. 2019;26(11):1429–38.PubMedCrossRef Hu KL, et al. Increased Expression of KISS1 and KISS1 Receptor in Human Granulosa Lutein Cells-Potential Pathogenesis of Polycystic Ovary Syndrome. Reprod Sci. 2019;26(11):1429–38.PubMedCrossRef
51.
go back to reference Li MG, et al. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2007;92(12):4771–6.PubMedCrossRef Li MG, et al. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2007;92(12):4771–6.PubMedCrossRef
52.
go back to reference Zhang C, et al. β-Edorphin predict pregnancy outcome of PCOS and DOR women after IVF-ET. Arch Gynecol Obstet. 2021;303(5):1207–16.PubMedCrossRef Zhang C, et al. β-Edorphin predict pregnancy outcome of PCOS and DOR women after IVF-ET. Arch Gynecol Obstet. 2021;303(5):1207–16.PubMedCrossRef
53.
go back to reference Liu Y, et al. Effect of sex hormone-binding globulin polymorphisms on the outcome of in vitro fertilization-embryo transfer for polycystic ovary syndrome patients: A case-control study. J Cell Biochem. 2019;120(3):4675–86.PubMedCrossRef Liu Y, et al. Effect of sex hormone-binding globulin polymorphisms on the outcome of in vitro fertilization-embryo transfer for polycystic ovary syndrome patients: A case-control study. J Cell Biochem. 2019;120(3):4675–86.PubMedCrossRef
54.
go back to reference Dewailly D, et al. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2020;11:641.PubMedCrossRef Dewailly D, et al. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2020;11:641.PubMedCrossRef
55.
go back to reference Shaaban Z, et al. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22(1):3–16.PubMedPubMedCentral Shaaban Z, et al. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22(1):3–16.PubMedPubMedCentral
57.
go back to reference Liu XH, Wu XH, Yang S. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes. Arch Gynecol Obstet. 2019;300(6):1773–83.PubMedCrossRef Liu XH, Wu XH, Yang S. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes. Arch Gynecol Obstet. 2019;300(6):1773–83.PubMedCrossRef
58.
go back to reference Chen Y, et al. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome. J Int Med Res. 2017;45(3):1138–47.PubMedPubMedCentralCrossRef Chen Y, et al. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome. J Int Med Res. 2017;45(3):1138–47.PubMedPubMedCentralCrossRef
59.
go back to reference Yilmaz N, et al. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome. Gynecol Endocrinol. 2012;28(3):162–5.PubMedCrossRef Yilmaz N, et al. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome. Gynecol Endocrinol. 2012;28(3):162–5.PubMedCrossRef
60.
go back to reference Zeydabadi Nejad S, Ramezani Tehrani F,Zadeh-Vakili A. The Role of Kisspeptin in Female Reproduction. Int J Endocrinol Metab. 2017;15(3):e44337. Zeydabadi Nejad S, Ramezani Tehrani F,Zadeh-Vakili A. The Role of Kisspeptin in Female Reproduction. Int J Endocrinol Metab. 2017;15(3):e44337.
61.
go back to reference Polak AM, et al. The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome. 2020;12(9):2753. Polak AM, et al. The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome. 2020;12(9):2753.
62.
go back to reference Maffei M, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995;1(11):1155–61.PubMedCrossRef Maffei M, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995;1(11):1155–61.PubMedCrossRef
63.
go back to reference Inal HA, et al. The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS. J Endocrinol Invest. 2016;39(4):431–7.PubMedCrossRef Inal HA, et al. The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS. J Endocrinol Invest. 2016;39(4):431–7.PubMedCrossRef
64.
go back to reference Bousmpoula A, et al. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecological Endocrinology. 2019;35(9):803–6.PubMedCrossRef Bousmpoula A, et al. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecological Endocrinology. 2019;35(9):803–6.PubMedCrossRef
65.
go back to reference Cumming DC, et al. EVIDENCE FOR DECREASED ENDOGENOUS DOPAMINE AND OPIOID INHIBITORY INFLUENCES ON LH SECRETION IN POLYCYSTIC OVARY SYNDROME. Clinical Endocrinology. 1984;20(6):643–8.PubMedCrossRef Cumming DC, et al. EVIDENCE FOR DECREASED ENDOGENOUS DOPAMINE AND OPIOID INHIBITORY INFLUENCES ON LH SECRETION IN POLYCYSTIC OVARY SYNDROME. Clinical Endocrinology. 1984;20(6):643–8.PubMedCrossRef
66.
go back to reference Guido M, et al. Involvement of Ovarian Steroids in the Opioid-Mediated Reduction of Insulin Secretion in Hyperinsulinemic Patients with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 1998;83(5):1742–5.CrossRef Guido M, et al. Involvement of Ovarian Steroids in the Opioid-Mediated Reduction of Insulin Secretion in Hyperinsulinemic Patients with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 1998;83(5):1742–5.CrossRef
68.
go back to reference Duran C, et al. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine. 2015;49(2):464–9.PubMedCrossRef Duran C, et al. Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome. Endocrine. 2015;49(2):464–9.PubMedCrossRef
69.
go back to reference Gao H, et al. Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in vitro fertilization. International Journal of Gynecology & Obstetrics. 2021;155(1):138–45.CrossRef Gao H, et al. Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in vitro fertilization. International Journal of Gynecology & Obstetrics. 2021;155(1):138–45.CrossRef
70.
go back to reference Nafiye Y, et al. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil Steril. 2010;93(6):1864–9.PubMedCrossRef Nafiye Y, et al. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil Steril. 2010;93(6):1864–9.PubMedCrossRef
71.
go back to reference Bousmpoula A, et al. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecol Endocrinol. 2019;35(9):803–6.PubMedCrossRef Bousmpoula A, et al. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecol Endocrinol. 2019;35(9):803–6.PubMedCrossRef
72.
go back to reference Gao H, et al. Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in vitro fertilization. Int J Gynaecol Obstet. 2021;155(1):138–45.PubMedCrossRef Gao H, et al. Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in vitro fertilization. Int J Gynaecol Obstet. 2021;155(1):138–45.PubMedCrossRef
74.
go back to reference Wang Y, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecological Endocrinology. 2019;35(12):1072–7.PubMedCrossRef Wang Y, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecological Endocrinology. 2019;35(12):1072–7.PubMedCrossRef
75.
go back to reference Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochemical Pharmacology. 2002;64(5):893–901.PubMedCrossRef Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochemical Pharmacology. 2002;64(5):893–901.PubMedCrossRef
76.
go back to reference Niu Z, et al. Associations Between Insulin Resistance, Free Fatty Acids, and Oocyte Quality in Polycystic Ovary Syndrome During In Vitro Fertilization. The Journal of Clinical Endocrinology & Metabolism. 2014;99(11):E2269–76.CrossRef Niu Z, et al. Associations Between Insulin Resistance, Free Fatty Acids, and Oocyte Quality in Polycystic Ovary Syndrome During In Vitro Fertilization. The Journal of Clinical Endocrinology & Metabolism. 2014;99(11):E2269–76.CrossRef
77.
79.
go back to reference Carstensen M, et al. Sfrp5 correlates with insulin resistance and oxidative stress. European Journal of Clinical Investigation. 2013;43(4):350–7.PubMedCrossRef Carstensen M, et al. Sfrp5 correlates with insulin resistance and oxidative stress. European Journal of Clinical Investigation. 2013;43(4):350–7.PubMedCrossRef
80.
go back to reference Hu Z, Deng H, Qu H. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Research and Clinical Practice. 2013;99(3):391–5.PubMedCrossRef Hu Z, Deng H, Qu H. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Research and Clinical Practice. 2013;99(3):391–5.PubMedCrossRef
81.
go back to reference Inal ZO, Inal HA, Erdem S. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Molecular Biology Reports. 2018;45(6):2037–44.PubMedCrossRef Inal ZO, Inal HA, Erdem S. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Molecular Biology Reports. 2018;45(6):2037–44.PubMedCrossRef
82.
go back to reference Brown HM, et al. ADAMTS1 Cleavage of Versican Mediates Essential Structural Remodeling of the Ovarian Follicle and Cumulus-Oocyte Matrix During Ovulation in Mice1. Biology of Reproduction. 2010;83(4):549–57.PubMedCrossRef Brown HM, et al. ADAMTS1 Cleavage of Versican Mediates Essential Structural Remodeling of the Ovarian Follicle and Cumulus-Oocyte Matrix During Ovulation in Mice1. Biology of Reproduction. 2010;83(4):549–57.PubMedCrossRef
84.
go back to reference Timur H, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics. 2015;32(11):1637–42.PubMedPubMedCentralCrossRef Timur H, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics. 2015;32(11):1637–42.PubMedPubMedCentralCrossRef
85.
go back to reference Niu Z, et al. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269-76.PubMedPubMedCentralCrossRef Niu Z, et al. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269-76.PubMedPubMedCentralCrossRef
86.
go back to reference Timur H, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. J Assist Reprod Genet. 2015;32(11):1637–42.PubMedPubMedCentralCrossRef Timur H, et al. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome. J Assist Reprod Genet. 2015;32(11):1637–42.PubMedPubMedCentralCrossRef
87.
go back to reference Inal ZO, Inal HA, Erdem S. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Mol Biol Rep. 2018;45(6):2037–44.PubMedCrossRef Inal ZO, Inal HA, Erdem S. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome. Mol Biol Rep. 2018;45(6):2037–44.PubMedCrossRef
88.
go back to reference Sun Y, et al. High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies. Toxicol Appl Pharmacol. 2019;365:101–11.PubMedCrossRef Sun Y, et al. High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies. Toxicol Appl Pharmacol. 2019;365:101–11.PubMedCrossRef
89.
90.
go back to reference Cate RL, et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45(5):685–98.PubMedCrossRef Cate RL, et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell. 1986;45(5):685–98.PubMedCrossRef
91.
go back to reference Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. The Journal of Clinical Endocrinology & Metabolism. 2020;105(11):3361–73.CrossRef Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. The Journal of Clinical Endocrinology & Metabolism. 2020;105(11):3361–73.CrossRef
92.
go back to reference Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology. 2018;182:27–36.PubMedCrossRef Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. The Journal of Steroid Biochemistry and Molecular Biology. 2018;182:27–36.PubMedCrossRef
93.
94.
go back to reference Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014: 360438.PubMedPubMedCentralCrossRef Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014: 360438.PubMedPubMedCentralCrossRef
96.
go back to reference Popko K, et al. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010;15 Suppl 2(Suppl 2):120-2. Popko K, et al. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese subjects. Eur J Med Res. 2010;15 Suppl 2(Suppl 2):120-2.
97.
go back to reference Vural P, et al. Tumor necrosis factor α (−308), interleukin-6 (−174) and interleukin-10 (−1082) gene polymorphisms in polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;150(1):61–5.CrossRef Vural P, et al. Tumor necrosis factor α (−308), interleukin-6 (−174) and interleukin-10 (−1082) gene polymorphisms in polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;150(1):61–5.CrossRef
98.
go back to reference Xie J, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cellular Signalling. 2013;25(11):2185–97.PubMedCrossRef Xie J, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cellular Signalling. 2013;25(11):2185–97.PubMedCrossRef
99.
go back to reference Merhi Z. Advanced glycation end products and their relevance in female reproduction. Human Reproduction. 2014;29(1):135–45.PubMedCrossRef Merhi Z. Advanced glycation end products and their relevance in female reproduction. Human Reproduction. 2014;29(1):135–45.PubMedCrossRef
100.
101.
go back to reference Lam PM, Haines C. Vascular endothelial growth factor plays more than an angiogenic role in the female reproductive system. Fertility and Sterility. 2005;84(6):1775–8.PubMedCrossRef Lam PM, Haines C. Vascular endothelial growth factor plays more than an angiogenic role in the female reproductive system. Fertility and Sterility. 2005;84(6):1775–8.PubMedCrossRef
102.
go back to reference Pepper MS, et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemical and Biophysical Research Communications. 1991;181(2):902–6.PubMedCrossRef Pepper MS, et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemical and Biophysical Research Communications. 1991;181(2):902–6.PubMedCrossRef
103.
go back to reference Peitsidis P, Agrawal R. Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Reproductive BioMedicine Online. 2010;20(4):444–52.PubMedCrossRef Peitsidis P, Agrawal R. Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Reproductive BioMedicine Online. 2010;20(4):444–52.PubMedCrossRef
104.
go back to reference Stanek MB, et al. Insulin and Insulin-Like Growth Factor Stimulation of Vascular Endothelial Growth Factor Production by Luteinized Granulosa Cells: Comparison between Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women. The Journal of Clinical Endocrinology & Metabolism. 2007;92(7):2726–33.CrossRef Stanek MB, et al. Insulin and Insulin-Like Growth Factor Stimulation of Vascular Endothelial Growth Factor Production by Luteinized Granulosa Cells: Comparison between Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women. The Journal of Clinical Endocrinology & Metabolism. 2007;92(7):2726–33.CrossRef
105.
go back to reference Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.PubMedPubMedCentralCrossRef Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41.PubMedPubMedCentralCrossRef
106.
go back to reference Schultz DR, Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum. 1990;20(3):129–47.PubMedCrossRef Schultz DR, Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum. 1990;20(3):129–47.PubMedCrossRef
Metadata
Title
Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review
Authors
Mafalda V. Moreira
Emídio Vale-Fernandes
Inês C. Albergaria
Marco G. Alves
Mariana P. Monteiro
Publication date
26-07-2023
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 6/2023
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-023-09819-z

Other articles of this Issue 6/2023

Reviews in Endocrine and Metabolic Disorders 6/2023 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare